Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Catheter-based Transendocardial Delivery of Autologous Bone Marrow-Derived Cells in Patients With Heart Failure Due to Dilated Cardiomyopathy

NCT01020968 is registered in ClinicalTrials.gov with Vericel Corporation as lead sponsor.

NCT NCT01020968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01020968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Catheter-based Transendocardial Delivery of Autologous Bone Marrow-Derived Cells in Patients With Heart Failure Due to Dilated Cardiomyopathy
Lead sponsor
Vericel Corporation
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2009
Completion date
December 5, 2013
Enrollment
22 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dilated cardiomyopathy